Gene therapy Market Growth Prospects, Developments Plans, Future Insights and Trends Analysis Till 2035 ( midwest.social )
Gene Therapy Market Overview
In the last six years, more than 18,000 patients have been enrolled in registered clinical trials focused on gene therapies. The number and geographical distribution of clinical trials are important indicators of both the therapeutic viability and future potential of innovative pharmacological interventions.Over the years, several pharmaceutical / biopharmaceutical companies have conducted extensive clinical studies for only those drug / therapy classes that are likely to translate into commercial success.
The gene therapy market is estimated to be worth $2.6 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 18.0% during the forecast period.
Key geographical regions of gene therapy market are US, Europe, Asia-Pacific and rest of the world. Moreover, the geographical distribution directly indicates the various markets that are open to receiving / adopting the intervention(s) under investigation. As more product candidates get approved by the regulatory authorities across the globe, the number of clinical trials across different global regions is anticipated to increase.
A steady increase in the number of clinical trials registered for the evaluation of gene therapies, during the period 2017-2022 (till April) was found. This increase can be attributed to the incessant efforts of several industry / non-industry players that are actively developing and testing different types of gene therapies for the treatment of a wide range of diseases.
Gene Therapy Market Segmentation
Gene Therapy Market include :Type of Therapy, Type of Gene Delivery Method Used, Type of Vector Used, Target Therapeutic Areas, Route of Administration, and Key Geographical Regions.It is also worth highlighting that, over the years, most of the trials were registered for the evaluation of oncological diseases.
There are several instances of mergers and acquisitions that have been established by various stakeholders engaged in the development of gene therapies, during the period 2015-2022 (till January) and across most of the instances both the acquirer and the acquired company were based in North America. This implies that in the current scenario, companies headquartered in North America are actively investing in consolidating their indigenous presence by acquiring more gene therapy developers. On the other hand, certain companies based in Europe are expanding their global reach by acquiring companies based in North America.
Further, most of the acquisitions in this domain were focused on providing access to novel technology / platform to the acquirer company. This is followed by acquisitions undertaken for therapeutic area consolidation.
Browse Complete Report at: https://www.rootsanalysis.com/reports/gene-therapies-market/268.html
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture catalysts, and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.
The research efforts are driven by a global team. The leadership team brings a wealth of experience within the sector. Their collective experience in pharmaceutical / affiliated domains allows us to tackle various areas of research in a structured way. We also regularly leverage our global network of experts who hold senior leadership positions in reputed firms and organizations worldwide.
All our analysts are trained to produce high-quality research work. They are continuously mentored by senior experts to present an original, unbiased and informed perspective on pressing issues in the industry. On any particular subject, we bring together the best available resources to ensure highest quality in all our reports.
Contact Details
Roots Analysis
Gaurav Chaudhary
+1 (415) 800 3415
+44 (122) 391 1091
[email protected]
Website: https://www.rootsanalysis.com/
